Oncogene-addicted NSCLC update from WCLC and ESMO 2024

In this video update, Dr Herbert H. Loong shares his perspective on the latest data on oncogene-addicted non-small cell lung cancer (NSCLC) to emerge from two important congresses, WCLC and ESMO 2024. Dr Loong reviews data from the following clinical trials (with corresponding video time stamps): 0:13 - TRUST-II 0:54 - LOXO-RAS-20001 1:47 - DESTINY-Lung03 3:02 - SOHO-01 & Beamion LUNG-1 4:07 - ALKOVE-1 5:29 - MARIPOSA Download the accompanying slides from the COR2ED website, where you will also find more updates from ESMO 2024 in our conference update video series: https://cor2ed.com/n-connect/programm... Prof. Nicolas Girard provided a similar highlights video, reviewing the NSCLC data presented at ASCO 2024. Find it here: https://cor2ed.com/lung-connect/progr... Subscribe to the COR2ED channel above to be the first to see new Independent Medical Education programmes as they are released. Follow LUNG CONNECT on social media: X – https://x.com/lung_connect LinkedIn –   / lungconnect   This content is intended for healthcare professionals only. Published September 2024 The medical experts in this video are expressing their own views and not those of COR2ED, Supporters or their institution. This video is supported by an Independent Education Grant from Bayer This video is developed by cor2ed.com